BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients
Clinical trial NCT01498172 · COMPLETED
Trial details
- NCT number
- NCT01498172
- Sponsor
- Patrice Jichlinski
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2015-02-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.